HIV self-testing was approved in Canada in November 2020, largely thanks to research conducted by REACH Nexus, part of Unity Health Toronto’s Map Centre for Urban Health Solutions. But approval does not mean access – the next step is getting self-tests into the hands of people who don’t know they have HIV, and linking them to follow-up treatment and care.
While the U=U message has been getting a lot of momentum in recent years, the role of HIV treatment in preventing HIV through other transmission routes is not as widely known. This information is important for informed healthcare decision making and further destigmatizing HIV.
The African and Caribbean Council on HIV/AIDS in Ontario (ACCHO) is a provincial coalition of organizations and individuals committed to HIV prevention, education, advocacy, research, treatment, care and support for African, Caribbean and Black (ACB) communities. They spoke to CATIE about the impact of COVID-19 in ACB communities, and their efforts to improve vaccine confidence.
HIV continues to be a global health threat, even amid the COVID-19 pandemic. In keeping with UNAIDS goals for reducing that burden, HIV prevention by PEP and PrEP have played major roles in reaching those goals. While PrEP has been instrumental in preventing HIV in people with high-risk exposures, we have seen gaps in HIV prevention strategies, especially among individuals who have less frequent exposures. This is where “pill-in-pocket PEP”, better known as PIP, has a substantial role to play.
To find out how the series It’s A Sin started a national dialogue about HIV in the United Kingdom, and what Canadian HIV organizations can learn from that experience, former CATIE board chair John McCullagh spoke to Ian Green, chief executive officer of Terrence Higgins Trust, the largest HIV charity in the United Kingdom.
Over the past five years, Ontario has seen a steady increase in the number of people using pre-exposure prophylaxis (PrEP). Between January and March 2020, 8,413 people were on PrEP – up from 289 in 2015. While most of these people live larger cities like Toronto and Ottawa, PrEP use has also increased in regions across the province.
